Skip to main content
Top
Published in: Internal and Emergency Medicine 6/2012

01-12-2012 | IM - ORIGINAL

Prevalence of horB gene among the Helicobacter pylori strains isolated from dyspeptic patients: first report from Iran

Authors: Tarang Taghvaei, Amin Talebi Bezmin Abadi, Ali Ghasemzadeh, Behnam Kalali Naderi, Ashraf Mohabbati Mobarez

Published in: Internal and Emergency Medicine | Issue 6/2012

Login to get access

Abstract

Helicobacter pylori (H. pylori) is globally accepted as an important cause of gastritis in human, and evidence strongly shows an etiological role for H. pylori in gastric cancer and peptic ulceration. In this study, we determined the relationship between digestive diseases and the horB gene of H. pylori infection. Fresh antral biopsy specimens were obtained from 140 dyspeptic patients (67 men and 73 women; mean age 41.5, aged 19–63 years). They were examined for presence of the horB gene of H. pylori clinical isolates. Bacterial DNA content was extracted directly from the antral biopsy. Statistical analysis was performed with SPSS version 16.0. Prevalence of the horB gene in H. pylori isolated from patients with gastric cancer, gastric ulcer, gastritis and duodenal ulcer is (5/32) 15.6%, (4/25) 16%, (30/43) 70%, and (9/40) 22.5%, respectively. No significant relationship is observed between age, pathologic findings and gender factors with respect to the four digestive diseases (P > 0.05). In our examination, a significant association was observed between a horB positive genotype of H. pylori and the occurrence of gastritis; in support of the protective theory. Studies with a higher sample size in different countries of the world should be conducted to obtain a thorough assessment as to whether horB has a role in the progress of gastritis (protective effect) or not. Further tests should be carried out to determine the exact role of horB in infection of H. pylori.
Literature
1.
go back to reference Basso D, Plebani M, Kusters JG (2010) Pathogenesis of Helicobacter pylori infection. Helicobacter 15:14–20PubMedCrossRef Basso D, Plebani M, Kusters JG (2010) Pathogenesis of Helicobacter pylori infection. Helicobacter 15:14–20PubMedCrossRef
2.
go back to reference Yamaoka Y (2008) Increasing evidence of the role of Helicobacter pylori SabA in the pathogenesis of gastroduodenal disease. J Infect Dev Ctries 2:174–181PubMedCrossRef Yamaoka Y (2008) Increasing evidence of the role of Helicobacter pylori SabA in the pathogenesis of gastroduodenal disease. J Infect Dev Ctries 2:174–181PubMedCrossRef
3.
go back to reference Olfat F, Zheng Q, Oleastro M, Voland P, Boren T, Karttunen R, Engstrand L, Rad R, Prinz C, Gerhard M (2005) Correlation of the Helicobacter pylori adherence factor BabA with duodenal ulcer disease in four European countries. FEMS Immunol Med Microbiol 44:151–156PubMedCrossRef Olfat F, Zheng Q, Oleastro M, Voland P, Boren T, Karttunen R, Engstrand L, Rad R, Prinz C, Gerhard M (2005) Correlation of the Helicobacter pylori adherence factor BabA with duodenal ulcer disease in four European countries. FEMS Immunol Med Microbiol 44:151–156PubMedCrossRef
4.
go back to reference Kusters JG, Vliet HM, Kuipers EJ (2006) Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19:449–490PubMedCrossRef Kusters JG, Vliet HM, Kuipers EJ (2006) Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19:449–490PubMedCrossRef
5.
go back to reference Testerman TL, McGee DJ, Mobley HLT (2001) Adherence and colonization. In: Mobley LT, Mendz GL, Hazell SL (eds) Helicobacter pylori: Physiology, Genetics. ASM Press, Washington, pp 381–417 Testerman TL, McGee DJ, Mobley HLT (2001) Adherence and colonization. In: Mobley LT, Mendz GL, Hazell SL (eds) Helicobacter pylori: Physiology, Genetics. ASM Press, Washington, pp 381–417
6.
go back to reference Blaser MJ, Atherton JC (2004) Helicobacter pylori persistence: biology and disease. J Clin Invest 113:321–333PubMed Blaser MJ, Atherton JC (2004) Helicobacter pylori persistence: biology and disease. J Clin Invest 113:321–333PubMed
7.
go back to reference Nguyen TN, Barkun AN, Fallone CA (1999) Host determinants of Helicobacter pylori infection and its clinical outcome. Helicobacter 4:185–197PubMedCrossRef Nguyen TN, Barkun AN, Fallone CA (1999) Host determinants of Helicobacter pylori infection and its clinical outcome. Helicobacter 4:185–197PubMedCrossRef
8.
go back to reference Tomb JF, White O, Kerlavage AR et al (1997) The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539–547PubMedCrossRef Tomb JF, White O, Kerlavage AR et al (1997) The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539–547PubMedCrossRef
9.
go back to reference Odenbreit S, Till M, Hofreuter D, Faller G, Haas R (1999) Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol Microbiol 31:1537–1548PubMedCrossRef Odenbreit S, Till M, Hofreuter D, Faller G, Haas R (1999) Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol Microbiol 31:1537–1548PubMedCrossRef
10.
go back to reference Yamaoka Y, Kwon DH, Graham DY (2000) A M(r) 34, 000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 97:7533–7538PubMedCrossRef Yamaoka Y, Kwon DH, Graham DY (2000) A M(r) 34, 000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 97:7533–7538PubMedCrossRef
11.
go back to reference Peck B, Ortkamp M, Diehl KD, Hundt E, Knapp B (1999) Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori. Nucl Acids Res 27:3325–3333PubMedCrossRef Peck B, Ortkamp M, Diehl KD, Hundt E, Knapp B (1999) Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori. Nucl Acids Res 27:3325–3333PubMedCrossRef
12.
go back to reference Takata T, El-Omar E, Camorlinga M, Thompson SA, Minohara Y, Ernst PB, Blaser MJ (2002) Helicobacter pylori does not require Lewis X or Lewis Y expression to colonize C3H/HeJ mice. Infect Immun 70:3073–3079PubMedCrossRef Takata T, El-Omar E, Camorlinga M, Thompson SA, Minohara Y, Ernst PB, Blaser MJ (2002) Helicobacter pylori does not require Lewis X or Lewis Y expression to colonize C3H/HeJ mice. Infect Immun 70:3073–3079PubMedCrossRef
13.
go back to reference Mahdavi J, Boren T, Vandenbroucke-Grauls C, Appelmelk BJ (2003) Limited role of lipopolysaccharide Lewis antigens in adherence of Helicobacter pylori to the human gastric epithelium. Infect Immun 71:2876–2880PubMedCrossRef Mahdavi J, Boren T, Vandenbroucke-Grauls C, Appelmelk BJ (2003) Limited role of lipopolysaccharide Lewis antigens in adherence of Helicobacter pylori to the human gastric epithelium. Infect Immun 71:2876–2880PubMedCrossRef
14.
go back to reference Alm RA, Bina J, Andrews BM, Doig P, Hancock RE, Trust TJ (2000) Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun 68:4155–4168PubMedCrossRef Alm RA, Bina J, Andrews BM, Doig P, Hancock RE, Trust TJ (2000) Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun 68:4155–4168PubMedCrossRef
15.
go back to reference Bina J, Bains M, Hancock RE (2000) Functional expression in Escherichia coli and membrane topology of porin HopE, a member of a large family of conserved proteins in Helicobacter pylori. J Bacteriol 182:2370–2375PubMedCrossRef Bina J, Bains M, Hancock RE (2000) Functional expression in Escherichia coli and membrane topology of porin HopE, a member of a large family of conserved proteins in Helicobacter pylori. J Bacteriol 182:2370–2375PubMedCrossRef
16.
go back to reference Snelling W, Moran AP et al (2007) HorB (HP0127) is a gastric epithelial cell adhesin. Helicobacter 12:200–209PubMedCrossRef Snelling W, Moran AP et al (2007) HorB (HP0127) is a gastric epithelial cell adhesin. Helicobacter 12:200–209PubMedCrossRef
17.
go back to reference Megraud F, Lehours P (2007) Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 20:280–322PubMedCrossRef Megraud F, Lehours P (2007) Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 20:280–322PubMedCrossRef
18.
go back to reference Marais A, Mendz GL, Hazell SL, Megraud F (1999) Metabolism and genetics of Helicobacter pylori: the genome era. Microbiol Mol Biol Rev 63:642–674PubMed Marais A, Mendz GL, Hazell SL, Megraud F (1999) Metabolism and genetics of Helicobacter pylori: the genome era. Microbiol Mol Biol Rev 63:642–674PubMed
19.
go back to reference Cordova Espinoza MG, Vazquez RG, Mendez IM, Vargas CR, Cerezo SG (2011) Detection of the glmM gene in Helicobacter pylori isolates with a novel primer by PCR. J Clin Microbiol. doi:10.1128/JCM.00461-10 Cordova Espinoza MG, Vazquez RG, Mendez IM, Vargas CR, Cerezo SG (2011) Detection of the glmM gene in Helicobacter pylori isolates with a novel primer by PCR. J Clin Microbiol. doi:10.​1128/​JCM.​00461-10
20.
go back to reference Kavermann H, Burns BP, Angermuller K et al (1999) Oral immunization with Helicobacter pylori-loaded poly (D, 1-lactide-co-glycolide) nanoparticles. Helicobacter 4:33–39CrossRef Kavermann H, Burns BP, Angermuller K et al (1999) Oral immunization with Helicobacter pylori-loaded poly (D, 1-lactide-co-glycolide) nanoparticles. Helicobacter 4:33–39CrossRef
21.
go back to reference Porwollik S, Noonan B, OToole PW (1999) Molecular characterization of a flagellar export locus of Helicobacter pylori. Infect Immun 67:2060–2070PubMed Porwollik S, Noonan B, OToole PW (1999) Molecular characterization of a flagellar export locus of Helicobacter pylori. Infect Immun 67:2060–2070PubMed
22.
go back to reference Mansour-Ghanaei F, Yousefi-Mashhour M, Joukar F, Sedigh M, Bagher-Zadeh AH, Jafarshad R (2009) Prevalence of Helicobacter pylori Infection among Children in Rasht, Northern Iran. Middle East J Dig Dis 1:84–88 Mansour-Ghanaei F, Yousefi-Mashhour M, Joukar F, Sedigh M, Bagher-Zadeh AH, Jafarshad R (2009) Prevalence of Helicobacter pylori Infection among Children in Rasht, Northern Iran. Middle East J Dig Dis 1:84–88
23.
go back to reference Malekzadeh R, Derakhshan MH, Malekzadeh Z (2009) Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med 12:576–583PubMed Malekzadeh R, Derakhshan MH, Malekzadeh Z (2009) Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med 12:576–583PubMed
24.
go back to reference Abadi ATB, Ajami A, Taghvaei T, Mobarez AM, Vaira G, Vaira D (2011) High correlation of babA2-positive strains of Helicobacter pylori with the presence of gastric cancer. Inter Emerg Med. doi:10.1007/s11739-011-0588-5 Abadi ATB, Ajami A, Taghvaei T, Mobarez AM, Vaira G, Vaira D (2011) High correlation of babA2-positive strains of Helicobacter pylori with the presence of gastric cancer. Inter Emerg Med. doi:10.​1007/​s11739-011-0588-5
25.
go back to reference Talebi Bezmin Abadi A, Ghasemzadeh A, Mohabbati Mobarez A (2011) Low frequency of cagA-positive Helicobacter pylori strains isolated from Iranian patients with MALT lymphoma. Intern Emerg Med. doi:10.1007/s11739-011-0579-6 Talebi Bezmin Abadi A, Ghasemzadeh A, Mohabbati Mobarez A (2011) Low frequency of cagA-positive Helicobacter pylori strains isolated from Iranian patients with MALT lymphoma. Intern Emerg Med. doi:10.​1007/​s11739-011-0579-6
26.
go back to reference Talebi Bezmin Abadi A, Ghasemzadeh A, Taghvaei T, Mohabbati Mobarez A (2011) Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. Intern Emerg Med. doi:10.1007/s11739-011-0563-1 Talebi Bezmin Abadi A, Ghasemzadeh A, Taghvaei T, Mohabbati Mobarez A (2011) Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. Intern Emerg Med. doi:10.​1007/​s11739-011-0563-1
Metadata
Title
Prevalence of horB gene among the Helicobacter pylori strains isolated from dyspeptic patients: first report from Iran
Authors
Tarang Taghvaei
Amin Talebi Bezmin Abadi
Ali Ghasemzadeh
Behnam Kalali Naderi
Ashraf Mohabbati Mobarez
Publication date
01-12-2012
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 6/2012
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-011-0614-7

Other articles of this Issue 6/2012

Internal and Emergency Medicine 6/2012 Go to the issue

CE - Cochrane Clinical Evidence and Health Technology Assessment

Multiple systematic reviews: methods for assessing discordances of results

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine